Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil Diwan joined Stev ...

Researchers at Leipzig University and Martin Luther University Halle-Wittenberg have investigated a previously unknown process that occurs during protein synthesis in the cell. They examined how ...

The Democratic Republic of Congo hasn’t reported any new cases of Ebola in the past 10 days at a time the nation is ramping up vaccination efforts to contain the disease. “This is giving some hope in ...

BULAPE, Congo — The World Health Organization announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases have been reported since Sept. 25.

Oct 8 (Reuters) - The Ebola outbreak in the Democratic Republic of the Congo shows signs of containment, with no new confirmed or probable cases since the World Health Organization's last update on ...

Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonists have shown encouraging results in osteoarthritis. More studies are needed to clearly ...